The first cannabis company on a major U.S. stock exchange failed to make a big splash in its Wall Street debut.
Shares opened at $20.25 but closed at $19.15 on Thursday for IIP, a San Diego, Calif.-based real estate investment trust for medical cannabis facilities.
Pot on the public markets
Weed news and interviews: Get podcasts of The Cannabist Show.
Subscribe to our newsletter here.
Watch The Cannabist Show.
Peruse our Cannabist-themed merchandise (T’s, hats, hoodies) at Cannabist Shop.
The company originally intended to sell 8.75 million shares at $20 per share. However, while some of the 2016 election results brought some good news for the company — medical and recreational marijuana measures passed in eight states — the ripple effects from the election of Donald Trump as president dampened the positive news, IPO analyst Matt Kennedy previously told The Cannabist.
Kennedy noted the recent nomination of Sen. Jeff Sessions, R-Ala. for the post of attorney general. Sessions has been outspoken against legalization efforts.
Ahead of the debut, IIP filed amended documents with the U.S. Securities and Exchange Commission stating its founders would forego receiving some stock as part of the IPO, and downsized its offering twice in three business days.